YBGJ — Yubo International Biotech Balance Sheet
0.000.00%
- $15.17m
- $15.29m
- $0.00m
Annual balance sheet for Yubo International Biotech, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 February 29th | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Short Term Investments | 0.001 | 0.028 | 0.018 | 0.006 | 0.007 |
Net Total Accounts Receivable | |||||
Net Total Receivables | — | 0.56 | 0.345 | 0.366 | 0.442 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Current Assets | 0.001 | 1.06 | 0.75 | 0.725 | 0.683 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | — | 3.34 | 1.41 | 0.767 | 0.685 |
Net Intangible Assets | |||||
Other Long Term Assets | |||||
Total Assets | 0.001 | 4.59 | 2.35 | 1.67 | 1.53 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 1.8 | 2.79 | 2.52 | 3.4 | 4.72 |
Total Long Term Debt | |||||
Total Debt | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 1.8 | 4.72 | 2.91 | 3.51 | 4.96 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | -1.8 | -0.131 | -0.565 | -1.84 | -3.42 |
Total Liabilities & Shareholders' Equity | 0.001 | 4.59 | 2.35 | 1.67 | 1.53 |
Total Common Shares Outstanding |